MICHAL GERBLICH: Open Payments
NPI 1770012429 · HARRISON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 22 payments from 6 companies in 2025. Trend: 2023 $1,167 · 2024 $948 · 2025 $947
Food & beverage: $947
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $383 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $191 |
| Ardelyx, Inc. | 3 | $162 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $157 |
| SANOFI PASTEUR INC. | 1 | $29 |
| Lilly USA, LLC | 1 | $25 |
Products named: ENTYVIO, IBSRELA, XIFAXAN, SKYRIZI, CREON, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, OMVOH.
Industry payments across NY — which companies pay providers there.
